How To Invest In Mesoblast Ltd Stock - MESO Share Price Today & News | Stash

Invest in Mesoblast Ltd on Stash

Mesoblast Limited is engaged in the development of regenerative medicine products.

To buy fractional shares of Mesoblast Ltd stock, you'll need to sign up for Stash and open a personal portfolio.

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Ticker: MESO

Mesoblast Ltd

$17.32

+16.79%

(1W)

Disclosure

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by LSEG Data & Analytics in partnership with: LSEG FX in collaboration with: LSEG Risk Intelligence. Stash cannot and does not represent or guarantee that any of the information available via LSEG Data & Analytics is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

MESO Performance Breakdown

About MESO

Mesoblast Limited is engaged in the development of regenerative medicine products. The Company’s regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high and unmet medical needs. The Company’s portfolio of Phase III product candidates comprises RYONCIL (remestemcel-L) for steroid-refractory acute graft versus host disease (acute GVHD), REVASCOR for advanced chronic heart failure (CHF) and MPC-06-ID for chronic low back pain due to degenerative disc disease. The Company's product candidate, MPC-150-IM, is in Phase III trials for the treatment of both advanced and end-stage CHF. The Company has conducted a Phase II trial of MPC-300-IV in patients with biologic-refractory rheumatoid arthritis. The Company is developing MPC-25-Osteo for spinal fusion.

How to buy Mesoblast Ltd stock on Stash

  1. Enter the amount you'd like to invest in Mesoblast Ltd stock, then proceed to checkout. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
  2. Set up your investment account in just a few minutes.
  3. Once you’ve finished your account, your Mesoblast Ltd shares will be added to your new portfolio.

You can continue to build your portfolio by buying more stocks and funds—there are hundreds of options on Stash.